Who owns the EYEQ FORMULATION trademark?

The EYEQ FORMULATION trademark is owned by Orasis Pharmaceuticals Ltd..

What class is the EYEQ FORMULATION trademark registered in?

The EYEQ FORMULATION trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for EYEQ FORMULATION?

The USPTO serial number for EYEQ FORMULATION is 99020672.

What is the registration number for EYEQ FORMULATION?

EYEQ FORMULATION is registered under USPTO registration number 8404846.

EYE

USPTO Trademark Record

REGISTERED

EYEQ FORMULATION

SN 99020672·Reg 8404846·Filed Jan 28, 2025

Owner Orasis Pharmaceuticals Ltd.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

EYEQ FORMULATION (Serial No. 99020672), Registration No. 8404846, is a registered US trademark filed on Jan 28, 2025 by Orasis Pharmaceuticals Ltd.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: August 18, 2032

Mark Intelligence

EYEQ FORMULATION (Reg. #8404846) is a registered US trademark that has been protecting its owner, Orasis Pharmaceuticals Ltd., since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 28, 2025

SERIAL

99020672

REG#

8404846

REGISTERED

Aug 18, 2026

Owner

Applicant

Orasis Pharmaceuticals Ltd.

Entity

Not Provided

Address

6 Maskit st., P.O.B 12929, Herzliya, 4673328

Country

Attorney

NameB. Brett Heavner

Law firm

B. Brett Heavner Finnegan Henderson Farabow Garrett & Dunner LLP

Docket

13954.0026

Address

901 New York Avenue NW, Washington, DC 20001, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJan 28, 2025

Serial Number99020672

Registration No.8404846

Registration DateAug 18, 2026

Status DateAug 18, 2026

Published for OppositionAug 19, 2025

Mark TypeStandard characters

Attorney Docket13954.0026

Status DescriptionLive and registered

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Apr 01, 2025

First use in commerce: Apr 01, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

28 events

REGISTERED-PRINCIPAL REGISTER

Aug 18, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 18, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 27, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 27, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jul 01, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Jul 01, 2026

STATEMENT OF USE PROCESSING COMPLETE

SOU TEAS EXTENSION RECEIVED

Apr 14, 2026

SOU TEAS EXTENSION RECEIVED

TEAS STATEMENT OF USE RECEIVED

Apr 14, 2026

TEAS STATEMENT OF USE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 14, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

USE AMENDMENT FILED

Apr 14, 2026

USE AMENDMENT FILED

SOU EXTENSION 1 GRANTED

Apr 14, 2026

SOU EXTENSION 1 GRANTED

SOU EXTENSION 1 FILED

Apr 14, 2026

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 14, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Aug 19, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 19, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 13, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jul 11, 2025

EXAMINER'S AMENDMENT ENTERED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 11, 2025

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 11, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT E-MAILED

Jul 11, 2025

EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Jul 11, 2025

EXAMINERS AMENDMENT -WRITTEN

ASSIGNED TO EXAMINER

Jul 08, 2025

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Jul 08, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 08, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 08, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION ENTERED

Jan 28, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Jan 28, 2025

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 28, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

EYEQ FORMULATION

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Orasis Pharmaceuticals Ltd.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by B. Brett Heavner

Resources

Company